Annual Shareholders Equity
$175.61 M
-$5.62 M-3.10%
December 31, 2021
Summary
- As of February 8, 2025, ALBO annual stockholders equity is $175.61 million, with the most recent change of -$5.62 million (-3.10%) on December 31, 2021.
- During the last 3 years, ALBO annual shareholders equity has risen by +$52.97 million (+43.19%).
Performance
ALBO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$100.07 M
-$13.61 M-11.97%
September 30, 2022
Summary
- As of February 8, 2025, ALBO quarterly stockholders equity is $100.07 million, with the most recent change of -$13.61 million (-11.97%) on September 30, 2022.
- Over the past year, ALBO quarterly shareholders equity has dropped by -$81.64 million (-44.93%).
Performance
ALBO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ALBO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.1% | -44.9% |
| 3 y3 years | +43.2% | -1.6% |
| 5 y5 years | +169.1% | +44.8% |
ALBO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -43.0% | at low |
| 5 y | 5-year | -3.1% | -46.9% | -52.7% | -10.9% |
| alltime | all time | -3.1% | -99.6% | -52.7% | -99.3% |
Albireo Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $100.07 M(-12.0%) |
| Jun 2022 | - | $113.68 M(-23.3%) |
| Mar 2022 | - | $148.19 M(-15.6%) |
| Dec 2021 | $175.61 M(-3.1%) | $175.61 M(-3.4%) |
| Sep 2021 | - | $181.72 M(+60.1%) |
| Jun 2021 | - | $113.50 M(-23.3%) |
| Mar 2021 | - | $147.92 M(-18.4%) |
| Dec 2020 | $181.23 M(+94.5%) | $181.23 M(-14.4%) |
| Sep 2020 | - | $211.76 M(+137.6%) |
| Jun 2020 | - | $89.12 M(-21.4%) |
| Mar 2020 | - | $113.43 M(+21.8%) |
| Dec 2019 | $93.16 M(-24.0%) | $93.16 M(-8.4%) |
| Sep 2019 | - | $101.67 M(-13.6%) |
| Jun 2019 | - | $117.69 M(+5.7%) |
| Mar 2019 | - | $111.39 M(-9.2%) |
| Dec 2018 | $122.64 M(+87.9%) | $122.64 M(-10.3%) |
| Sep 2018 | - | $136.67 M(-8.6%) |
| Jun 2018 | - | $149.45 M(-6.7%) |
| Mar 2018 | - | $160.17 M(+145.5%) |
| Dec 2017 | $65.25 M(+76.6%) | $65.25 M(-5.6%) |
| Sep 2017 | - | $69.12 M(-8.1%) |
| Jun 2017 | - | $75.25 M(+141.1%) |
| Mar 2017 | - | $31.21 M(+18.0%) |
| Dec 2016 | $36.95 M(+39.8%) | - |
| Sep 2016 | - | $26.44 M(-5.4%) |
| Sep 2016 | $26.44 M(-33.2%) | - |
| Jun 2016 | - | $27.96 M(-9.8%) |
| Mar 2016 | - | $31.00 M(-15.0%) |
| Dec 2015 | - | $36.45 M(-7.8%) |
| Sep 2015 | $39.56 M(+73.5%) | $39.56 M(-6.7%) |
| Jun 2015 | - | $42.39 M(+159.3%) |
| Mar 2015 | - | $16.35 M(-13.4%) |
| Dec 2014 | - | $18.88 M(-17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | $22.80 M(-30.0%) | $22.80 M(+6.7%) |
| Jun 2014 | - | $21.37 M(-12.7%) |
| Mar 2014 | - | $24.49 M(-19.5%) |
| Dec 2013 | - | $30.43 M(-6.6%) |
| Sep 2013 | $32.56 M(+5.0%) | $32.56 M(+1.4%) |
| Jun 2013 | - | $32.10 M(+39.4%) |
| Mar 2013 | - | $23.02 M(-17.5%) |
| Dec 2012 | - | $27.90 M(-10.1%) |
| Sep 2012 | $31.02 M(-16.3%) | $31.02 M(-16.1%) |
| Jun 2012 | - | $36.96 M(+22.0%) |
| Mar 2012 | - | $30.28 M(-9.4%) |
| Dec 2011 | - | $33.44 M(-9.8%) |
| Sep 2011 | $37.08 M(+54.1%) | $37.08 M(+16.3%) |
| Jun 2011 | - | $31.88 M(+99.3%) |
| Mar 2011 | - | $16.00 M(-20.9%) |
| Dec 2010 | - | $20.24 M(-15.9%) |
| Sep 2010 | $24.06 M(-52.4%) | $24.06 M(-3.1%) |
| Jun 2010 | - | $24.84 M(-21.8%) |
| Mar 2010 | - | $31.75 M(-22.2%) |
| Dec 2009 | - | $40.82 M(-19.2%) |
| Sep 2009 | $50.54 M(-42.9%) | $50.54 M(-15.5%) |
| Jun 2009 | - | $59.84 M(-14.0%) |
| Mar 2009 | - | $69.57 M(-12.9%) |
| Dec 2008 | - | $79.86 M(-9.7%) |
| Sep 2008 | $88.49 M(+14.6%) | $88.49 M(-12.0%) |
| Jun 2008 | - | $100.60 M(-7.4%) |
| Mar 2008 | - | $108.67 M(+57.7%) |
| Dec 2007 | - | $68.91 M(-10.8%) |
| Sep 2007 | $77.22 M(+372.4%) | $77.22 M(-9.1%) |
| Jun 2007 | - | $84.95 M(+841.4%) |
| Mar 2007 | - | $9.02 M(-31.4%) |
| Dec 2006 | - | $13.16 M(-19.5%) |
| Sep 2006 | $16.35 M(+2399.7%) | $16.35 M(+2399.7%) |
| Sep 2005 | $654.00 K | $654.00 K |
FAQ
- What is Albireo Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Albireo Pharma?
- What is Albireo Pharma annual shareholders equity year-on-year change?
- What is Albireo Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Albireo Pharma?
- What is Albireo Pharma quarterly shareholders equity year-on-year change?
What is Albireo Pharma annual stockholders equity?
The current annual shareholders equity of ALBO is $175.61 M
What is the all time high annual shareholders equity for Albireo Pharma?
Albireo Pharma all-time high annual stockholders equity is $181.23 M
What is Albireo Pharma annual shareholders equity year-on-year change?
Over the past year, ALBO annual stockholders equity has changed by -$5.62 M (-3.10%)
What is Albireo Pharma quarterly stockholders equity?
The current quarterly shareholders equity of ALBO is $100.07 M
What is the all time high quarterly shareholders equity for Albireo Pharma?
Albireo Pharma all-time high quarterly stockholders equity is $211.76 M
What is Albireo Pharma quarterly shareholders equity year-on-year change?
Over the past year, ALBO quarterly stockholders equity has changed by -$81.64 M (-44.93%)